0.9958 USD
-0.02 (-2.37%)
1.02 USD
+0.02 (+2.43%)
Overall RNXT gets a fundamental rating of 3 out of 10. We evaluated RNXT against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for RNXT as it has an excellent financial health rating, but there are worries on the profitability. RNXT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
- RNXT had negative earnings in the past year.
- RNXT had a negative operating cash flow in the past year.
- RNXT had negative earnings in each of the past 5 years.
- RNXT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -99.10%, RNXT is doing worse than 74.29% of the companies in the same industry.
- Looking at the Return On Equity, with a value of -137.47%, RNXT is doing worse than 62.48% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -99.1% | ||
| ROE | -137.47% | ||
| ROIC | N/A |
ROA(3y)-314.19%
ROA(5y)-236.06%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Gross Margin value of 67.78%, RNXT belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
- RNXT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 67.78% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- RNXT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- RNXT has more shares outstanding than it did 1 year ago.
- RNXT has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for RNXT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- RNXT has an Altman-Z score of -2.50. This is a bad value and indicates that RNXT is not financially healthy and even has some risk of bankruptcy.
- RNXT has a Altman-Z score (-2.50) which is comparable to the rest of the industry.
- There is no outstanding debt for RNXT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.5 |
ROIC/WACCN/A
WACC8.88%
2.3 Liquidity
- A Current Ratio of 5.83 indicates that RNXT has no problem at all paying its short term obligations.
- RNXT's Current ratio of 5.83 is fine compared to the rest of the industry. RNXT outperforms 61.33% of its industry peers.
- RNXT has a Quick Ratio of 5.68. This indicates that RNXT is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 5.68, RNXT is in the better half of the industry, outperforming 61.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.83 | ||
| Quick Ratio | 5.68 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 36.21% over the past year.
EPS 1Y (TTM)36.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%20%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- RNXT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.56% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y18.4%
EPS Next 2Y5.24%
EPS Next 3Y23.26%
EPS Next 5Y22.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for RNXT. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RNXT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- RNXT's earnings are expected to grow with 23.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.24%
EPS Next 3Y23.26%
5. Dividend
5.1 Amount
- No dividends for RNXT!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
RENOVORX INC / RNXT FAQ
What is the ChartMill fundamental rating of RENOVORX INC (RNXT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to RNXT.
What is the valuation status for RNXT stock?
ChartMill assigns a valuation rating of 1 / 10 to RENOVORX INC (RNXT). This can be considered as Overvalued.
What is the profitability of RNXT stock?
RENOVORX INC (RNXT) has a profitability rating of 1 / 10.
What is the earnings growth outlook for RENOVORX INC?
The Earnings per Share (EPS) of RENOVORX INC (RNXT) is expected to grow by 18.4% in the next year.